Kieffer Tara Lynn
Chief Product Strategy Officer · 5 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Tax withholding | 3,257 | $14.25 | $46,412.25 | filing |
| 2026-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Award | 1,575 | $0.00 | $0.00 | filing |
| 2026-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Award | 4,987 | $0.00 | $0.00 | filing |
| 2025-12-05 | ENTA | ENANTA PHARMACEUTICALS INC | Sale | 2,106 | $14.23 | $29,968.38 | filing |
| 2025-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Tax withholding | 753 | $14.12 | $10,632.36 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.